Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
暂无分享,去创建一个
P. Rosenthal | N. Chalasani | J. Hoofnagle | M. V. Van Natta | D. Kleiner | A. Sanyal | J. Tonascia | E. Brunt | J. Schwimmer | J. Lavine | K. Murray | A. Ünalp | S. Abrams | J. Molleston | Patricia R. Robuck | A. Scheimann | J. Clark
[1] C. Moskaluk,et al. Hepatocellular ballooning in NASH. , 2010, Journal of hepatology.
[2] E. Jackvony,et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis , 2010, Hepatology.
[3] P. Rosenthal,et al. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. , 2010, Contemporary clinical trials.
[4] D. Houlihan,et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.
[5] C. Sirlin,et al. Advances in pediatric nonalcoholic fatty liver disease , 2009, Hepatology.
[6] M. V. Van Natta,et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. , 2008, Gastroenterology.
[7] J. Schwimmer,et al. Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease , 2008, Circulation.
[8] M. Manco,et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial , 2008, Hepatology.
[9] Jeffrey B. Schwimmer,et al. Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.
[10] C. Nievergelt,et al. Histopathology of pediatric nonalcoholic fatty liver disease , 2005, Hepatology.
[11] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[12] R. Deutsch,et al. A phase 2 clinical trial of metformin as a treatment for non‐diabetic paediatric non‐alcoholic steatohepatitis , 2005, Alimentary pharmacology & therapeutics.
[13] S. Sanderson,et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.
[14] R. Deutsch,et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. , 2003, The Journal of pediatrics.
[15] O. Cummings,et al. 160 Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) , 2003 .
[16] J. Teckman,et al. Obese children with steatohepatitis can develop cirrhosis in childhood , 2002, American Journal of Gastroenterology.
[17] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[18] J. Lavine. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. , 2000, The Journal of pediatrics.
[19] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[20] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.